Back to search

Switzerland· 51306031

Lamisil 125 mg, Tabletten

A terbinafine product containing terbinafinum, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC D01BA02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedLamisil 125 mg, TablettenATCD01BA02REGISTER NO.51306031PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Terbinafine is registered in 12 of 19 countries.

Countries holding a registration under ATC D01BA02 (terbinafine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Terbinafine · ATC D01BA02

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of terbinafine costs, country by country.

Normalised to the WHO defined daily dose (0.25 g), the median price runs from $1.38 in Italy to $3.55 in Switzerland — a ×2.6 gap.

  • Switzerland: $3.55 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Terbinafine · price per daily dose (0.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.55
  • IT Italy$1.38
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
terbinafinum
Manufacturer
Novartis Pharma Schweiz AG
Country
Switzerland (CH)
ATC code
D01BA02
ATC class
Terbinafine
Defined daily dose
0.25 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680513060314
    14 Stk
    CHF 39.65

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

375 interactions on record for terbinafine.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Terbinafine · interactions on record

375 records

  • 16 severe
  • 128 moderate
  • 11 minor
  • 202 info

Most severe, free to view

  • EliglustatA16AX10severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe

18 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Terbinafine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terbinafine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Amykal, Lamisil
  • Belgium · Lamisil, Lamisil Dermgel
  • Bulgaria · Exoterbyn, Ербинол
  • Cyprus · Chemiderm, Chemiderm Τοπικό Αντιμυκnτιασικό Φάρμακο
  • Czechia · Lamisil, Terbinafin Actavis
  • Germany · Fungizid Extra, Lamisil
  • Denmark · Finigen, Lamisil
  • Estonia · Exotafin, Lamisil
  • Spain · Lamisil, Pevaryl Uñas
  • Finland · Fungorin, Lamisil
  • France · Fungster, Lamisil
  • United Kingdom (Northern Ireland) · Boots Athlete's Foot, Lamisil
  • Greece · Anaplas, Chemiderm
  • Croatia · Atere, Exoterbyn
  • Hungary · Exoterbyn, Lamisil Derma
  • Ireland · Fungasil, Lamisil
  • Iceland · Lamisil, Lamisil Once
  • Italy · Lamisil, Micutan
  • Lithuania · Lamisil, Lamisil Dermgel
  • Luxembourg · Lamisil, Lamisil Dermgel
  • Latvia · Exotafin, Lamisil
  • Malta · Fungasil, Fungasil 250mg Tablets
  • Netherlands · Antischimmelcrème Terbinafine Hcl Htp, Binanidda
  • Norway · Lamisil, Lamisil Dermgel
  • Poland · Erfin, Lamisilatt
  • Portugal · Fungur, Lamisil
  • Romania · Exoterfyn, Fungisil Mk
  • Sweden · Azurifin, Lamisil
  • Slovenia · Exoter, Lamisil
  • Slovakia · Exoterin, Lamisil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eedc1d15-5de2-4b3a-82e3-2fb42b77f30d
GET /v1/drugs/eedc1d15-5de2-4b3a-82e3-2fb42b77f30d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "terbinafinum 125 mg",
  "valid_from": "1995-03-15",
  "limitations": null,
  "galenic_form": "Tabl 125 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1995-03-15",
  "self_retention_pct": 10
}

See everything about terbinafine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.